Nexalin Technology, Inc. Share Price
Equities
NXL
US65345B2016
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | -4.69% | -11.59% | +201.38% |
10/05 | Nexalin Technology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
25/04 | Nexalin Technology Regains Compliance With Nasdaq Listing Requirement | MT |
Sales 2022 | 1.32M 110M | Sales 2023 | 111K 9.24M | Capitalization | 3.01M 251M |
---|---|---|---|---|---|
Net income 2022 | -1M -83.46M | Net income 2023 | -4M -334M | EV / Sales 2022 | -0.59 x |
Net cash position 2022 | 6.24M 521M | Net cash position 2023 | 2.94M 246M | EV / Sales 2023 | 0.6 x |
P/E ratio 2022 |
-2.46
x | P/E ratio 2023 |
-0.64
x | Employees | 6 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.08% |
1 day | -4.69% | ||
1 week | -11.59% | ||
Current month | -20.26% | ||
1 month | -38.38% | ||
3 months | +293.42% | ||
6 months | +258.82% | ||
Current year | +201.38% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 19/10/19 | |
Mark White
CEO | Chief Executive Officer | 62 | 01/18/01 |
David Owens
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslie Bernhard
CHM | Chairman | 80 | - |
Mark White
CEO | Chief Executive Officer | 62 | 01/18/01 |
Alan Kazden
BRD | Director/Board Member | 63 | 01/19/01 |
Date | Price | Change | Volume |
---|---|---|---|
13/24/13 | 1.22 | -4.69% | 27 024 |
10/24/10 | 1.28 | +10.34% | 66,030 |
09/24/09 | 1.16 | -4.13% | 31,622 |
08/24/08 | 1.21 | -6.92% | 41,031 |
07/24/07 | 1.3 | -5.80% | 36,062 |
Delayed Quote Nasdaq, May 13, 2024 at 11:20 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+201.38% | 9.52M | |
+11.00% | 226B | |
+9.05% | 188B | |
+13.06% | 137B | |
+25.82% | 108B | |
+0.34% | 63.19B | |
+11.57% | 52.26B | |
+5.62% | 51B | |
+6.28% | 43.89B | |
+4.85% | 38.07B |
- Stock Market
- Equities
- NXL Stock